Form 4: Dynavax Director Scott Myers Boosts Stake with New Equity Grants

Dynavax Technologies Corp. Director Scott Myers acquired 5,758 restricted stock units and 28,500 stock options on June 11, 2025, aligning his interests further with shareholders.

Summary

• Scott Dunseth Myers, a Director of Dynavax Technologies Corp. (DVAX), reported the acquisition of new equity securities.
• On June 11, 2025, Mr. Myers acquired 5,758 shares of Common Stock in the form of Restricted Stock Units (RSUs) at a price of $0 per share.
• Following this transaction, Mr. Myers beneficially owns 31,204 shares of Common Stock.
• Each RSU represents a contingent right to receive one share of DVAX Common Stock and will fully vest one year from the grant date (June 11, 2025), provided continued service to the company.
• The release of RSU shares is mandatorily deferred six months and one day after Mr. Myers no longer provides services to the company.
• Additionally, Mr. Myers acquired 28,500 Stock Options (Right to Buy) with an exercise price of $10.18 per share.
• These stock options also fully vest and become exercisable one year from the grant date (June 11, 2025), contingent on continued service.
• The stock options have an expiration date of June 10, 2032.
• Following this transaction, Mr. Myers beneficially owns 28,500 derivative securities (stock options).

Sentiment

Score: 7

Explanation: The sentiment is positive as a director's acquisition of equity, particularly through compensation grants, indicates alignment of interests with shareholders and confidence in the company's future prospects. It is a routine, expected event but still a positive signal.

Positives

• The acquisition of additional equity by a director, particularly through grants of RSUs and stock options, aligns management's interests directly with those of shareholders.
• The vesting schedule, tied to continued service, incentivizes long-term commitment and performance from the director.

Risks

• No specific risks related to company operations or financial health are disclosed in this Form 4 filing, which primarily reports insider transactions.

Future Outlook

The document indicates that the newly acquired Restricted Stock Units and Stock Options will vest one year from the grant date (June 11, 2025), contingent upon the reporting person's continued service to the company. The RSU shares will be mandatorily deferred six months and one day after service termination.

Industry Context

This Form 4 filing reports a standard equity compensation grant to a director, a common practice across various industries to incentivize and retain key personnel and align their interests with company performance and shareholder value.

Comparison to Industry Standards

• The grant of Restricted Stock Units (RSUs) and stock options to a director is a standard component of executive and director compensation packages across publicly traded companies.
• The vesting period of one year is a common practice designed to encourage retention and long-term commitment.
• The exercise price of the options ($10.18) is likely based on the market price at the time of grant, which is typical for incentive stock options.

Related Party Transactions

• The acquisition of Restricted Stock Units and Stock Options by Scott Dunseth Myers, a Director of Dynavax Technologies Corp., constitutes a related party transaction as it involves compensation from the company to a member of its board.

Stakeholder Impact

• Shareholders: The transaction aligns the director's financial interests with those of the shareholders, potentially leading to more shareholder-friendly decisions and long-term value creation.
• Employees: While not directly impacting all employees, the compensation structure for leadership can influence overall company culture and compensation philosophies.

Next Steps

• The Restricted Stock Units and Stock Options are expected to vest one year from the grant date, contingent on continued service.

Key Dates

Keywords

Dynavax Technologies Corp, DVAX, Scott Myers, SEC Form 4, Insider Transaction, Restricted Stock Units, RSUs, Stock Options, Equity Compensation, Director, Beneficial Ownership